Literature DB >> 17627607

Cargo-dependent cytotoxicity and delivery efficacy of cell-penetrating peptides: a comparative study.

Samir El-Andaloussi1, Peter Järver, Henrik J Johansson, Ulo Langel.   

Abstract

The use of CPPs (cell-penetrating peptides) as delivery vectors for bioactive molecules has been an emerging field since 1994 when the first CPP, penetratin, was discovered. Since then, several CPPs, including the widely used Tat (transactivator of transcription) peptide, have been developed and utilized to translocate a wide range of compounds across the plasma membrane of cells both in vivo and in vitro. Although the field has emerged as a possible future candidate for drug delivery, little attention has been given to the potential toxic side effects that these peptides might exhibit in cargo delivery. Also, no comprehensive study has been performed to evaluate the relative efficacy of single CPPs to convey different cargos. Therefore we selected three of the major CPPs, penetratin, Tat and transportan 10, and evaluated their ability to deliver commonly used cargos, including fluoresceinyl moiety, double-stranded DNA and proteins (i.e. avidin and streptavidin), and studied their effect on membrane integrity and cell viability. Our results demonstrate the unfeasibility to use the translocation efficacy of fluorescein moiety as a gauge for CPP efficiency, since the delivery properties are dependent on the cargo used. Furthermore, and no less importantly, the toxicity of CPPs depends heavily on peptide concentration, cargo molecule and coupling strategy.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17627607      PMCID: PMC2049024          DOI: 10.1042/BJ20070507

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  27 in total

1.  Deletion analogues of transportan.

Authors:  U Soomets; M Lindgren; X Gallet; M Hällbrink; A Elmquist; L Balaspiri; M Zorko; M Pooga; R Brasseur; U Langel
Journal:  Biochim Biophys Acta       Date:  2000-07-31

2.  Cell-penetrating peptides. A reevaluation of the mechanism of cellular uptake.

Authors:  Jean Philippe Richard; Kamran Melikov; Eric Vives; Corinne Ramos; Birgit Verbeure; Mike J Gait; Leonid V Chernomordik; Bernard Lebleu
Journal:  J Biol Chem       Date:  2002-10-30       Impact factor: 5.157

3.  Insight into the mechanism of the peptide-based gene delivery system MPG: implications for delivery of siRNA into mammalian cells.

Authors:  Federica Simeoni; May C Morris; Frederic Heitz; Gilles Divita
Journal:  Nucleic Acids Res       Date:  2003-06-01       Impact factor: 16.971

Review 4.  The use of cell-penetrating peptides as a tool for gene regulation.

Authors:  Peter Järver; Ulo Langel
Journal:  Drug Discov Today       Date:  2004-05-01       Impact factor: 7.851

Review 5.  Cell penetrating peptides in drug delivery.

Authors:  Eric L Snyder; Steven F Dowdy
Journal:  Pharm Res       Date:  2004-03       Impact factor: 4.200

6.  Cell penetration by transportan.

Authors:  M Pooga; M Hällbrink; M Zorko; U Langel
Journal:  FASEB J       Date:  1998-01       Impact factor: 5.191

7.  A truncated HIV-1 Tat protein basic domain rapidly translocates through the plasma membrane and accumulates in the cell nucleus.

Authors:  E Vivès; P Brodin; B Lebleu
Journal:  J Biol Chem       Date:  1997-06-20       Impact factor: 5.157

8.  The third helix of the Antennapedia homeodomain translocates through biological membranes.

Authors:  D Derossi; A H Joliot; G Chassaing; A Prochiantz
Journal:  J Biol Chem       Date:  1994-04-08       Impact factor: 5.157

9.  Restoration of the tumor suppressor function to mutant p53 by a low-molecular-weight compound.

Authors:  Vladimir J N Bykov; Natalia Issaeva; Alexandre Shilov; Monica Hultcrantz; Elena Pugacheva; Peter Chumakov; Jan Bergman; Klas G Wiman; Galina Selivanova
Journal:  Nat Med       Date:  2002-03       Impact factor: 53.440

10.  Transducible TAT-HA fusogenic peptide enhances escape of TAT-fusion proteins after lipid raft macropinocytosis.

Authors:  Jehangir S Wadia; Radu V Stan; Steven F Dowdy
Journal:  Nat Med       Date:  2004-02-08       Impact factor: 53.440

View more
  60 in total

1.  Cell-penetrating peptides split into two groups based on modulation of intracellular calcium concentration.

Authors:  Annely Lorents; Praveen Kumar Kodavali; Nikita Oskolkov; Ülo Langel; Mattias Hällbrink; Margus Pooga
Journal:  J Biol Chem       Date:  2012-03-21       Impact factor: 5.157

2.  Anti-obesity and anti-tumor pro-apoptotic peptides are sufficient to cause release of cytochrome c from vesicles.

Authors:  Cristina M Sandoval; Bridget Salzameda; Kristine Reyes; Taylor Williams; Valerie S Hohman; Leigh A Plesniak
Journal:  FEBS Lett       Date:  2007-11-05       Impact factor: 4.124

3.  Assessment of SYBR green I dye-based fluorescence assay for screening antimalarial activity of cationic peptides and DNA intercalating agents.

Authors:  Rakesh Bhatia; Ankur Gautam; Shailendra K Gautam; Divya Mehta; Vinod Kumar; Gajendra P S Raghava; Grish C Varshney
Journal:  Antimicrob Agents Chemother       Date:  2015-02-17       Impact factor: 5.191

4.  Tumor targeting of a cell penetrating peptide by fusing with a pH-sensitive histidine-glutamate co-oligopeptide.

Authors:  Likun Fei; Li-Peng Yap; Peter S Conti; Wei-Chiang Shen; Jennica L Zaro
Journal:  Biomaterials       Date:  2014-02-06       Impact factor: 12.479

5.  Tuning the PEG surface density of the PEG-PGA enveloped Octaarginine-peptide Nanocomplexes.

Authors:  Eleni Samaridou; Nikolaos Kalamidas; Irene Santalices; José Crecente-Campo; Maria José Alonso
Journal:  Drug Deliv Transl Res       Date:  2020-02       Impact factor: 4.617

Review 6.  Cell penetrating peptide inhibitors of nuclear factor-kappa B.

Authors:  J S Orange; M J May
Journal:  Cell Mol Life Sci       Date:  2008-11       Impact factor: 9.261

7.  Nuclear localization of cell-penetrating peptides is dependent on endocytosis rather than cytosolic delivery in CHO cells.

Authors:  Jennica L Zaro; Jacqueline E Vekich; Thuy Tran; Wei-Chiang Shen
Journal:  Mol Pharm       Date:  2009 Mar-Apr       Impact factor: 4.939

8.  Bifunctional chimeric fusion proteins engineered for DNA delivery: optimization of the protein to DNA ratio.

Authors:  Shan Gao; Melissa J Simon; Barclay Morrison; Scott Banta
Journal:  Biochim Biophys Acta       Date:  2009-03

9.  The antimicrobial peptide NK-2, the core region of mammalian NK-lysin, kills intraerythrocytic Plasmodium falciparum.

Authors:  Christoph Gelhaus; Thomas Jacobs; Jörg Andrä; Matthias Leippe
Journal:  Antimicrob Agents Chemother       Date:  2008-03-10       Impact factor: 5.191

10.  The presence of alpha-catenin in the VE-cadherin complex is required for efficient transendothelial migration of leukocytes.

Authors:  Jaap D van Buul; Floris P van Alphen; Peter L Hordijk
Journal:  Int J Biol Sci       Date:  2009-11-09       Impact factor: 6.580

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.